Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. Fu S, Yao S, Yuan Y, Previs RA, et al. J Clin Oncol 2023;41:1725-1734.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fu S, Yao S, Yuan Y, Previs RA, et al. Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. J Clin Oncol 2023;41:1725-1734.
PMID: 36469840